19-8 Hospital applies advanced technology in cancer treatment

In addition to treatments such as chemotherapy and targeted therapy, immunotherapy is considered a superior method in the treatment of non-small cell lung cancer and colon cancer, helping late-stage patients prolong their lives, improve their quality of life, and open up a new future for early-stage cancer patients.

On the morning of June 6, 19/8 Hospital ( Ministry of Public Security ) organized an international conference "Updating advanced technology in cancer diagnosis and treatment: Breakthrough in personalized medicine".

Attending the workshop were leading cancer experts; the reporters were professors from Daegu Gyeongbuk Institute of Science and Technology, Seoul National University; Bertis Biotechnology Company, Korea; representatives of hospitals in the People's Public Security Forces and police clinics in some localities.

In his opening speech, Colonel, Associate Professor, Dr. Hoang Thanh Tuyen, Director of Hospital 19-8, said that cancer is a topical issue, so personalized treatment methods are increasingly receiving attention. Immunotherapy has been considered a breakthrough in cancer treatment. This method designs treatment regimens based on the genetic and molecular biological characteristics of each person's tumor, helping to significantly improve survival rates and quality of life.

Assoc. Prof. Dr. Hoang Thanh Tuyen delivered the opening speech of the workshop.

Individualized factors in treatment involve many factors such as genes, environmental influences in daily life, other influencing factors, etc. When examining a patient, the doctor must comprehensively understand these factors of the patient, the risk factors, and from there, come up with the most appropriate treatment regimen for each patient.

From 2010 to present, with the remarkable development of protein research technology using high-resolution mass spectrometry and new generation DNA and RNA gene sequencing technology, these are technologies that revolutionize the field of molecular biology and medicine, allowing the detection and quantification of the expression of tens of thousands of genes or proteins in the same tissue sample, providing the basis for finding markers for earlier and more accurate diagnosis and treatment of diseases.

Delegates attending the workshop.

As a result, revolutionary progress also creates a large database, requiring different analytical, processing and evaluation skills than traditional methods. Currently in developed countries, the development of AI technology helps to process and simplify large, individual-specific biological data systems, helping us better understand the pathogenesis, disease manifestations and support clinicians to make objective, scientific and accurate decision-making options based on highly quantitative test evidence.

"We organized the workshop with the aim of providing medical staff and doctors at the Public Security Medical Center with access to advanced knowledge about personalization in treatment, especially cancer. The workshop aims at three major goals: Helping the medical team access and better understand the role of gene and protein research in modern medicine, thereby promoting its application in clinical practice; creating a bridge of cooperation between researchers, scientists and clinicians to promote the transfer of technology and research results into actual treatment; affirming the hospital's development orientation to become a prestigious center for research, training and international cooperation in the field of personalized medicine and cancer treatment", shared the Director of Hospital 19-8.

Delegates listened to the reporter present an update on advanced technology in cancer treatment.

Currently, 19-8 Hospital cooperates with SETA Vietnam Joint Stock Company and some Japanese medical facilities with leading experts to conduct in-depth research on immunotherapy in cancer. Research results show that this therapy is very effective in treating some types of cancer such as lung cancer and colorectal cancer.

"At our hospital, there are patients with stage 3 colon cancer that have metastasized, but thanks to a combination of many treatments, especially immunotherapy, the patients still have a very good quality of life. The same goes for patients with lung cancer, especially in the late stages, thanks to a combination of traditional and immunotherapy treatments, the results are positive," said the Director of Hospital 19-8.

Colonel Hoang Thanh Tuyen presented flowers to the reporters.

According to the Director of 19-8 Hospital, in cooperation with Japanese partners, patients treated here will have their cells sent to Japan for filtering, culturing, and activating the ability to recognize diseased cells, then brought back to Vietnam for treatment of the patient. Japanese partners support part of the cost of treating patients using this method, so the cost of each treatment is lower than usual, helping many patients have access.

Source: https://cand.com.vn/y-te/benh-vien-19-8-ung-dung-cong-nghe-tien-tien-trong-dieu-tri-ung-thu--i770770/